Nanosonics Ltd
ASX:NAN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.63
4.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nanosonics Ltd
Nanosonics Ltd
Total Liabilities & Equity
Nanosonics Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nanosonics Ltd
ASX:NAN
|
Total Liabilities & Equity
AU$237.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
22%
|
|
|
Polynovo Ltd
ASX:PNV
|
Total Liabilities & Equity
AU$108.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
31%
|
CAGR 10-Years
28%
|
|
|
SDI Ltd
ASX:SDI
|
Total Liabilities & Equity
AU$140.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Total Liabilities & Equity
AU$45.7m
|
CAGR 3-Years
53%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Total Liabilities & Equity
$3.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Next Science Ltd
ASX:NXS
|
Total Liabilities & Equity
$17.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Nanosonics Ltd
Glance View
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
See Also
What is Nanosonics Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
237.3m
AUD
Based on the financial report for Jun 30, 2024, Nanosonics Ltd's Total Liabilities & Equity amounts to 237.3m AUD.
What is Nanosonics Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
22%
Over the last year, the Total Liabilities & Equity growth was 8%. The average annual Total Liabilities & Equity growth rates for Nanosonics Ltd have been 14% over the past three years , 13% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
